The β-oxidation of valproic acid (VPA; 2-n-propylpentanoic acid) was investigated in vitro in intact rat liver mitochondria incubated with 3H-labelled VPA. The metabolism of [4,5-3H2]VPA and [2-3H]VPA was studied by analysing the different acyl-CoA intermediates formed by reverse-phase HPLC with radiochemical detection. Valproyl-CoA, Δ2(E)-valproyl-CoA,3-hydroxyvalproyl-CoA and 3-oxovalproyl-CoA (labelled and non-labelled) were determined using continuous on-line radiochemical and UV detection. The formation of these intermediates was investigated using the two tritiated precursors in respiratory states 3 and 4. Valproyl-CoA was present at highest concentrations under both conditions. Two distinct labelled peaks were found, which were identified as 3H2O and [4,5-3H2]3-oxo-VPA. The formation of 3H2O strongly suggested that VPA underwent complete β-oxidation and that [4,5-3H2]3-oxo-VPA was formed by hydrolysis of the corresponding thioester. The hypothesis that 3-oxovalproyl-CoA undergoes thiolytic cleavage was investigated further. For this purpose a mito chondrial lysate was incubated with synthetic 3-oxovalproyl-CoA, carnitine and carnitine acetyltransferase for subsequent monitoring of the formation of propionylcarnitine and pentanoylcarnitine using electrospray ionization tandem MS. The detection of these compounds demonstrated unequivocally that the intermediate 3-oxovalproyl-CoA is a substrate of a mitochondrial thiolase, producing propionyl-CoA and pentanoyl-CoA, thus demonstrating the complete β-oxidation of VPA in the mitochondrion. Our data should lead to a re-evaluation of the generally accepted concept that the biotransformation of VPA by mitochondrial β-oxidation is incomplete.
Skip Nav Destination
Close
Article navigation
March 2002
- PDF Icon PDF LinkFront Matter
Research Article|
March 08 2002
Complete β-oxidation of valproate: cleavage of 3-oxovalproyl-CoA by a mitochondrial 3-oxoacyl-CoA thiolase
Margarida F. B. SILVA
;
Margarida F. B. SILVA
∗Department of Clinical Chemistry and Paediatrics, University of Amsterdam, Academic Medical Centre, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands
†Centro de Patogénese Molecular, Faculdade de Farmácia da Universidade de Lisboa, Av. Prof. Gama Pinto, 1649-003 Lisboa, Portugal
Search for other works by this author on:
Jos P. N. RUITER
;
Jos P. N. RUITER
∗Department of Clinical Chemistry and Paediatrics, University of Amsterdam, Academic Medical Centre, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands
Search for other works by this author on:
Henk OVERMARS
;
Henk OVERMARS
∗Department of Clinical Chemistry and Paediatrics, University of Amsterdam, Academic Medical Centre, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands
Search for other works by this author on:
Albert H. BOOTSMA
;
Albert H. BOOTSMA
∗Department of Clinical Chemistry and Paediatrics, University of Amsterdam, Academic Medical Centre, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands
Search for other works by this author on:
Albert H. van GENNIP
;
Albert H. van GENNIP
∗Department of Clinical Chemistry and Paediatrics, University of Amsterdam, Academic Medical Centre, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands
Search for other works by this author on:
Cornelis JAKOBS
;
Cornelis JAKOBS
‡Department of Clinical Chemistry, Free University Hospital, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands
Search for other works by this author on:
Marinus DURAN
;
Marinus DURAN
∗Department of Clinical Chemistry and Paediatrics, University of Amsterdam, Academic Medical Centre, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands
Search for other works by this author on:
Isabel TAVARES de ALMEIDA
;
Isabel TAVARES de ALMEIDA
1
†Centro de Patogénese Molecular, Faculdade de Farmácia da Universidade de Lisboa, Av. Prof. Gama Pinto, 1649-003 Lisboa, Portugal
1To whom correspondence should be addressed (e-mail italmeida@ff.ul.pt).
Search for other works by this author on:
Ronald J. A. WANDERS
Ronald J. A. WANDERS
∗Department of Clinical Chemistry and Paediatrics, University of Amsterdam, Academic Medical Centre, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands
Search for other works by this author on:
Biochem J (2002) 362 (3): 755–760.
Article history
Received:
July 20 2001
Revision Received:
November 16 2001
Accepted:
December 19 2001
Citation
Margarida F. B. SILVA, Jos P. N. RUITER, Henk OVERMARS, Albert H. BOOTSMA, Albert H. van GENNIP, Cornelis JAKOBS, Marinus DURAN, Isabel TAVARES de ALMEIDA, Ronald J. A. WANDERS; Complete β-oxidation of valproate: cleavage of 3-oxovalproyl-CoA by a mitochondrial 3-oxoacyl-CoA thiolase. Biochem J 15 March 2002; 362 (3): 755–760. doi: https://doi.org/10.1042/bj3620755
Download citation file:
Close
Sign in
Don't already have an account? Register
Sign in to your personal account
You could not be signed in. Please check your email address / username and password and try again.
Biochemical Society Member Sign in
Sign InSign in via your Institution
Sign in via your InstitutionGet Access To This Article
4
Views
0
Citations
Cited By
Related Articles
Identification and characterization of an intracellular protein complex that binds fibroblast growth factor-2 in bovine brain
Biochem J (July,1999)
Suppression of adipogenesis by valproic acid through repression of USF1-activated fatty acid synthesis in adipocytes
Biochem J (April,2014)
Structural model of carnitine palmitoyltransferase I based on the carnitine acetyltransferase crystal
Biochem J (May,2004)
Employing multiple models, methods and mechanisms in bipolar disorder research
Biochem Soc Trans (September,2009)